MedAware
Medication safety monitoring platform that uses machine learning and outlier detection to flag patient- and provider-specific medication risks.
Last updated: June 5, 2026
Back to directoryBayesian dosing platform for clinical practice that uses patient characteristics, drug concentrations, and validated pharmacokinetic models to support dose optimization.
Clinical pharmacy teams standardizing precision dosing and therapeutic drug monitoring workflows across high-risk medications.
Compare within workflow: Medication safety and dosing · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating DoseMeRx as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as high-risk medication dosing decision support and verify local clearance, intended use, drug-model scope, and clinician accountability before production use. |
|---|---|
| Privacy | Review patient demographics, lab data, medication levels, genotype fields, EHR integration, hosting, HITRUST evidence, BAA terms, retention, and access controls. |
| Evidence | Validate drug-model fit, lab-timing assumptions, local patient mix, outcome claims, and dosing recommendations against stewardship or pharmacy protocols. |
| Workflow | Best used inside pharmacist-led dosing programs with documented review, lab-quality checks, escalation rules, and dose-change signoff. |
DoseMeRx describes itself as a Bayesian dosing platform for clinical practice, using clinically validated pharmacokinetic models, patient characteristics, and drug concentrations to guide dose optimization; product pages also describe HITRUST certification, integrations, and support for multiple therapeutic areas.
Not for: Medication selection, independent prescribing, or dosing decisions without clinician review, lab-quality checks, and local stewardship governance.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.